Contracts › 75A50122C00010
75A50122C00010: This Contract Is to Advance the Development of a Second-Generation, Multi-Analyte Molecular Sars-Cov-2 and Influenza A/B Test That Has a Reduced Time to Result and Increased Sensitivity That Can Be Used at Home or a Poc Setting
Awarded to Detect Inc by Office of Assistant Secretary for Preparedness and Response.
$25.5Mobligated
$34.7Mpotential value
26 October 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50122C00010 |
|---|---|
| Awardee | Detect Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | CT |
| Offers received | 1 |
| Period of performance | 24 January 2022 to 26 October 2026 |
| Potential end | 26 October 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record